HCM Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan HUTCHMED

HUTCHMED Ltd - logo grafis emiten HCM

HUTCHMED (China) Limited (HCM) share price dynamics are largely independent of GDP, as demand for oncology therapy remains stable. Quarterly EPS growth on the GURU.Markets platform shows peaks, with the latest reading at -88.70. HUTCHMED (China) Limited attracts leading scientists by combining Eastern ethics with Western standards. High R&D costs are gradually offset by the global scaling of approved drugs.

Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan HUTCHMED (HCM): kanggo periode 04.07.2022 - 16.11.2026

Rincian metrik lan analitis perusahaan HUTCHMED (HCM)

- rega saham lan prakiraan rega para ahli:
Analisis komprehensif perusahaan:HUTCHMED Ltd, HCM
Barang unggulan hutch-med.com

Asset managers require an objective tool to assess an issuer's financial stability. This indicator measures the dynamics of net earnings per share, filtering out market noise to highlight the true trajectory of profitability. By analyzing the quarterly EPS growth trend, an investor determines the business's ability to generate cash flow. For HUTCHMED (HCM), this growth confirms the effective commercialization of Fruquintinib. High barriers to switching protocols in oncology therapy make the positive dynamics of this metric a long-term driver of capitalization.

Karo sapa HUTCHMED (China) Limited saingan

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan NUVB|DAWN (dayonebio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan monopartx.com (MNPR)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Inhibrx Corp (INBX)|IMAB - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Fennec Pharmaceuticals Inc FENC|Heron Therapeutics - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NVCT - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan coherus.com|CRBP: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Cardiff Oncology, Inc. CRDF|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BYSI|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BioAtla BCAB|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan LIXT (Lixte Biotechnology)|CTXR (Citius Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Cellectar Biosciences - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BLRX (BioLineRx)|Can-Fite BioPharma, Ltd. - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan APRE (aprea.com)|KZIA: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Silexion (SLXN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nucana.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc